Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review

Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review

Background: Early diagnosis of long QT type 3 (LQT3) syndrome during the neonatal period is of paramount clinical importance. LQT3 syndrome results in increased mortality and a mutation-specific response to treatment compared to other more common types of LQT syndrome. Mexiletine, a sodium channel b...

Full description

Bibliographic Details
Main Authors: Alena Bagkaki, Alexandros Tsoutsinos, Eleftheria Hatzidaki, Manolis Tzatzarakis, Fragiskos Parthenakis, Ioannis Germanakis
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pediatrics
Subjects:
LQT syndrome
LQT3
mexiletine
SCN5A mutation
neonate
child
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.674041/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2021.674041/full

Similar Items